First AD

Second AD

Combination Therapies for MF Management

Myeloproliferative Neoplasms

INC-22-OSD1258 - /clinical/myeloproliferative-neoplasms

The OncLive Myeloproliferative Neoplasms condition center is a comprehensive resource for clinical news and expert insights on myeloproliferative neoplasms, including myelofibrosis, polycythemia vera, and essential thrombocythemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in myeloproliferative neoplasms.

Hematologic Oncology

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Polycythemia Vera and Myelofibrosis: Current and Future Standards of Care

Peer Exchange

Panel experts comment on the role of combination therapies in MF and debate if these therapies will be the new standard of care.

Diagnosing Polycythemia Vera (PV)

Polycythemia Vera: Assessing Risk and Genetic Testing 

Polycythemia Vera: Treatment Goals and Options

REVEAL Study: Clinical Implications

Polycythemia Vera: Choosing the Right Treatment 

MAJIC-PV: Clinical Implications in PV

Role of Transplant in Myelofibrosis

Myelofibrosis: FDA Approved Treatment Options and Updates from ASH 2023

Treating Patients with Myelofibrosis and Anemia

Monitoring Patients on Myelofibrosis Treatment 

Future of PV: Unmet Needs

Future of MF